Cite
HARVARD Citation
Findling, O. et al. (2021). Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?. Drug discovery today. 26 (2), pp. 416-428. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Findling, O. et al. (2021). Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?. Drug discovery today. 26 (2), pp. 416-428. [Online].